Information about Kempen Pharma
My details
*
*
*

Kempen Pharma (SRL)

Company information

Status
Active

Enterprise number

BE0538.871.226

VAT liability
Yes
Established
18-09-2013
Last balance sheet year
2024
Company size
Medium-sized 0 FTE
Principal activity
Activities of holding companies
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

7-day free trial, no credit card required.

Financial data from Kempen Pharma

2024 2023 2022 2021
Profit/Loss 224,238 -68 % 700,790 290 % 179,868 -31 % 259,937
Equity 2,184,318 10 % 1,987,800 51 % 1,317,010 13 % 1,160,992
Gross margin 261,112 0 % 260,179 4 % 250,802 2 % 246,433

Publications from Kempen Pharma

Date Publication
16-06-2023 Articles of Association (Translation, Coordination, Other Modifications, …) - Modification Legal Form - Resignations - Appointments (NL)
07-10-2016 Registered Office (NL)
03-10-2013 Rubric Constitution (New Juridical Person, Opening Branch, etc...) (NL)

Frequently asked questions

What is the VAT number of Kempen Pharma?
The VAT number of Kempen Pharma is BE 0538.871.226.
Wat is the PEPPOL ID of Kempen Pharma?
The PEPPOL ID of Kempen Pharma is 0208:0538871226. Log in or start a free trial to see the full overview.
When was Kempen Pharma founded?
Kempen Pharma was founded on 18-09-2013.
What is the address of Kempen Pharma?
The current registered office of Kempen Pharma is located at Wiezelo 11, 2990 Wuustwezel.
When was the last time Kempen Pharma filed their annual financial statements?
The most recent financial statements of Kempen Pharma were filed on 20-08-2025.
How many employees does Kempen Pharma have?
There are currently no employees working at Kempen Pharma or no workforce information is available.
What is the annual turnover of Kempen Pharma?
At the time of its most recent financial statements, Kempen Pharma did not publish any turnover figures. Kempen Pharma reported a gross margin of €261,111.84.